E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/1/2005 in the Prospect News PIPE Daily.

New Issue: Norwood Abbey raises $10 million from private placement with U.S. investors

By Sheri Kasprzak

New York, Sept. 1 - Norwood Abbey Ltd. said it has entered into agreements with investors in the United States for a $10 million convertible note offering.

The notes will be issued in two tranches of $5 million each with the notes issued in the first tranche bearing interest at 3.5% annually and the notes issued in the second tranche bearing interest at 4.5% annually.

The notes from the first tranche mature in two years and the notes from the second in three years. The conversion price for both is A$0.42.

Indus Capital Partners subscribed for $7 million of the offering, and Tiedemann Global Emerging Markets subscribed for the remaining $3 million.

The offering comes with attached options for 8,335,000 shares, exercisable at A$0.65 each for four years.

The funds from the deal will be used to meet obligations associated with Norwood's CIBA Vision EyeCare purchase agreement. The rest will be used for working capital.

Based in Victoria, Australia, Norwood Abbey develops products used in laser eye surgery and other optical procedures.

First tranche

Issuer:Norwood Abbey Ltd.
Issue:Convertible notes (first tranche)
Amount:$5 million
Maturity:Two years
Coupon:3.5%
Price:Par
Yield:3.5%
Conversion price:A$0.42
Options:For 8,335,000 shares
Options expiration:Four years
Options price:A$0.65
Investors:Indus Capital Partners and Tiedemann Global Emerging Markets
Settlement date:Sept. 1
Stock price:A$0.395 at close Sept. 1
Second tranche
Issuer:Norwood Abbey Ltd.
Issue:Convertible notes (second tranche)
Amount:$5 million
Maturity:Three years
Coupon:4.5%
Price:Par
Yield:4.5%
Conversion price:A$0.42
Options:See above
Investors:Indus Capital Partners and Tiedemann Global Emerging Markets
Settlement date:Sept. 1
Stock price:A$0.395 at close Sept. 1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.